Impact of SomaSignal Tests on the Choice of Glucose-lowering Medications

计划入组 350 人 · 首次发布于 2021 年 12 月 21 日

SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes

计划入组 143 人 · 首次发布于 2022 年 2 月 25 日

Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study

计划入组 12 人 · 首次发布于 2021 年 4 月 8 日

Iopromide(Ultravist)

C₁₈H₂₄I₃N₃O₈

Technetium Tc-99m

Tc

Neon

Ne

Sona Nanotech Inc

Canada

Zoetis

United States

Biora Therapeutics

United States

Illumina Completes $350 Million Acquisition of SomaLogic to Expand Proteomics Leadership

OncoPrism-HNSCC Biomarker Test Shows Superior Predictive Accuracy for Head and Neck Cancer Immunotherapy

Fox Chase Trial Explores Active Surveillance for Muscle-Invasive Bladder Cancer